首页> 外文OA文献 >PCN169 Evaluating the Burden of Bone Metastases (BM) on Patients with Castration-Resistant Prostate Cancer (CRPC) and Their Treating Physicians: Findings from a Routine Practice Study in 13 Medium-Sized European Countries

【2h】

PCN169 Evaluating the Burden of Bone Metastases (BM) on Patients with Castration-Resistant Prostate Cancer (CRPC) and Their Treating Physicians: Findings from a Routine Practice Study in 13 Medium-Sized European Countries

机译：PCN169评估去势抵抗性前列腺癌（CRPC）及其治疗医师的骨转移负担（BM）：来自欧洲13个中型国家的例行实践研究的结果

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Hechmati G.; Vrouchou P.; Arellano J.; Cristino J.; Haynes I.; Liede A.; Rider A.; Worsfold A.; Pollard R.; Crossland V.;
展开▼
作者单位

展开▼
年度 2013
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Phase II Clinical Study of Radium-223 Chloride (BAY 88-8223) in Japanese Patients With Symptomatic Castration-Resistant Prostate Cancer (CRPC) With Bone Metastases [J] . Neal D. Shore Clinical advances in hematology & oncology: H&O . 2016,第4Suppla5期

机译：日本有症状的去势抵抗性前列腺癌（CRPC）骨转移患者的223氯化镭（BAY 88-8223）II期临床研究
2. 79 POSTER Correlative results of in-vivo monitoring of platelet-derived growth factor receptor (PDGFR) activation status in a randomized placebocontrolled trial of docetaxel +/? imatinib in castration-resistant prostate cancer (CRPC) and bone metastases (BM) [J] . P.Mathew, P.F.Thall, S.Wen, European Journal of Cancer Supplements . 2006,第12期

机译：79 POSTER在多西他赛+ /？的随机安慰剂对照试验中，体内监测血小板衍生的生长因子受体（PDGFR）激活状态的相关结果。伊马替尼治疗去势抵抗性前列腺癌（CRPC）和骨转移（BM）
3. Radium-223 dichloride (Ra-223) improves survival in patients (pts) with castration-resistant prostate cancer (CRPC) and symptomatic bone metastases (mets): nursing roles in implementing this new treatment (tx) option [J] . European journal of oncology nursing: the official journal of European Oncology Nursing Society . 2014,第Suppla1期

机译：二氯化镭（Ra-223）可改善去势抵抗性前列腺癌（CRPC）和有症状骨转移（mets）的患者（pts）的生存：在实施这种新治疗（tx）方案中的护理作用
4. A real-world study assessing the use of bone-targeted agents and their impact on bone metastases in patients with prostate cancer treated in clinical practice in Europe [O] . Jean-Jacques Body, Roger von Moos, Alex Rider, 2019

机译：一项评估在欧洲临床实践中治疗的前列腺癌患者中骨靶向药物的使用及其对骨转移影响的真实世界研究
5. PCN111 Impact Of Bone Metastases (Bm) On The Humanistic Burden In Patients With Castration-Resistant Prostate Cancer (Crpc) [O] . Hechmati G., Arellano J., Haynes I., 2013

机译：PCN111对去势抵抗性前列腺癌（Crpc）患者的骨转移（Bm）对人道负担的影响

PCN169 Evaluating the Burden of Bone Metastases (BM) on Patients with Castration-Resistant Prostate Cancer (CRPC) and Their Treating Physicians: Findings from a Routine Practice Study in 13 Medium-Sized European Countries

著录项

引文网络

相似文献

相关主题

期刊订阅